José Chang
Impact in
- Hematology top 5%
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Neutropenia and Cancer Infections
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 6
- Neutropenia and Cancer Infections 4
- HER2/EGFR in Cancer Research 3
- Cancer survivorship and care 3
-
- Erythropoietin and Anemia Treatment 5
- Co-authors
- Félix Couture (5 shared papers)Catherine Y. Lau (3 shared papers)Scott Young (1 shared paper)George Dranitsaris (2 shared papers)Mark Vincent (2 shared papers)Daniel Rayson (2 shared papers)Karen A. Gelmon (2 shared papers)Kathleen I. Pritchard (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Breast Cancer Research and Treatment (2 papers)The Oncologist (2 papers)Psycho-Oncology (1 paper)Clinical Breast Cancer (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
José Chang
17 papers receiving 597 citations
Peers
Comparison fields: 5 of 65
- Hematology 174
- Oncology 384
- Biochemistry 45
- Genetics 80
- Pulmonary and Respiratory Medicine 186
Countries citing papers authored by José Chang
This map shows the geographic impact of José Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Chang more than expected).
Fields of papers citing papers by José Chang
This network shows the impact of papers produced by José Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Chang. The network helps show where José Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside José Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 138 | |
| 2 | 2000 | 93 | |
| 3 | 2010 | 70 | |
| 4 | 2009 | 64 | |
| 5 | 2007 | 48 | |
| 6 | 2008 | 42 | |
| 7 | 2002 | 37 | |
| 8 | 2013 | 24 | |
| 9 | 2008 | 23 | |
| 10 | 2004 | 19 | |
| 11 | 2004 | 17 | |
| 12 | 2012 | 10 | |
| 13 | 2006 | 8 | |
| 14 | 2013 | 7 | |
| 15 | Safety of Dual Antiplatelet Therapy After Carotid Endarterectomy for Prevention of Restenosis: A Single Center Experience. | 2016 | 5 |
| 16 | 2021 | 3 | |
| 17 | 2005 | 2 |
About José Chang
José Chang is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Genetics and Biochemistry, having authored 17 papers that have together received 610 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Erythropoietin and Anemia Treatment (5 papers), Neutropenia and Cancer Infections (4 papers), Blood transfusion and management (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer survivorship and care (3 papers), Cancer-related cognitive impairment studies (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Hematology (174 citations), Oncology (384 citations), Biochemistry (45 citations), Genetics (80 citations) and Pulmonary and Respiratory Medicine (186 citations). José Chang has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Félix Couture, Catherine Y. Lau, Scott Young, George Dranitsaris, Mark Vincent, Daniel Rayson, Karen A. Gelmon, Kathleen I. Pritchard, Patrick Neven and M. Macpherson. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, The Oncologist, Psycho-Oncology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.